Elisabeth Heath

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Seattle Genetics
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Seattle Genetics
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Zenith
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Agensys
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Oncolys
    Date added:
    Date updated:
    04/13/2022
Return to Global Advancements in Prostate Cancer: The Role of Genetic Testing and PARP Inhibitors (2022) - English